Keystone Bio has identified and is targeting a "one of a kind Inflammapath ", the keystone pathogen of chronic inflammation that’s been shown to initiate and advance Atherosclerosis, Heart disease and Alzheimer's disease.Keystone Bio is a nextgen PharmaBiome biotech that has identified and is targeting a "one of a kindInflammapath ", the keystone pathogen of chronic inflammation that’s been shown to initiate and advance Atherosclerosis, Heart disease and Alzheimer's disease.

Michael Rafii

Senior Medical Advisor, Neuro at Keystone Bio

Org chart

Teams

Advisory Team

Offices

Related people

Kailas Bharambe

Samantha Avivi

Andi Lawrence-Harrison

Jonovan Acosta

Myra R.